X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (206472) 206472
Publication (22992) 22992
Book Review (1656) 1656
Book Chapter (1262) 1262
Conference Proceeding (496) 496
Dissertation (263) 263
Magazine Article (233) 233
Newsletter (192) 192
Book / eBook (145) 145
Web Resource (67) 67
Reference (60) 60
Trade Publication Article (27) 27
Data Set (17) 17
Government Document (17) 17
Journal / eJournal (17) 17
Newspaper Article (13) 13
Paper (4) 4
Streaming Video (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (111254) 111254
humans (86179) 86179
male (76633) 76633
index medicus (65282) 65282
rats (54025) 54025
female (45525) 45525
pharmacology & pharmacy (38513) 38513
neurosciences (34948) 34948
mice (30659) 30659
dose-response relationship, drug (23327) 23327
rats, sprague-dawley (19879) 19879
adult (19795) 19795
biochemistry & molecular biology (17329) 17329
middle aged (16181) 16181
agonists (16037) 16037
agonist (14739) 14739
rats, wistar (14150) 14150
in vitro techniques (13244) 13244
cells, cultured (12278) 12278
expression (11302) 11302
ligands (11267) 11267
time factors (11158) 11158
activation (11026) 11026
receptors (10793) 10793
article (10459) 10459
aged (10041) 10041
rat (9828) 9828
adrenergic beta-agonists - pharmacology (9413) 9413
physiology (9150) 9150
brain (9061) 9061
analysis (8861) 8861
endocrinology & metabolism (8847) 8847
chemistry, medicinal (8773) 8773
psychiatry (8462) 8462
mice, inbred c57bl (8346) 8346
research (8252) 8252
treatment outcome (8197) 8197
cell biology (8073) 8073
disease models, animal (8035) 8035
cell line (7891) 7891
neurons (7884) 7884
receptor (7753) 7753
clinical neurology (7733) 7733
adrenergic alpha-agonists - pharmacology (7649) 7649
neurons - drug effects (7346) 7346
structure-activity relationship (7056) 7056
signal transduction (7046) 7046
dopamine (7022) 7022
physiological aspects (6783) 6783
calcium - metabolism (6716) 6716
cells (6512) 6512
immunology (6374) 6374
binding (6078) 6078
inhibition (5968) 5968
adolescent (5923) 5923
signal transduction - drug effects (5820) 5820
serotonin receptor agonists - pharmacology (5763) 5763
pharmacology (5658) 5658
double-blind method (5509) 5509
apoptosis (5504) 5504
in-vitro (5489) 5489
pregnancy (5451) 5451
inflammation (5437) 5437
dopamine agonists - pharmacology (5278) 5278
phosphorylation (5247) 5247
excitatory amino acid agonists - pharmacology (5202) 5202
isoproterenol - pharmacology (5199) 5199
in-vivo (5110) 5110
drug interactions (5048) 5048
mice, knockout (5033) 5033
care and treatment (5013) 5013
antagonists (4946) 4946
health aspects (4932) 4932
double-blind (4915) 4915
kinetics (4912) 4912
proteins (4904) 4904
serotonin (4886) 4886
behavior, animal - drug effects (4842) 4842
neurons - metabolism (4841) 4841
blood pressure - drug effects (4695) 4695
asthma (4663) 4663
adrenergic beta-agonists - therapeutic use (4633) 4633
cardiac & cardiovascular systems (4630) 4630
antagonist (4620) 4620
asthma - drug therapy (4611) 4611
motor activity - drug effects (4565) 4565
multidisciplinary sciences (4556) 4556
rodents (4494) 4494
brain - metabolism (4481) 4481
chemistry, organic (4441) 4441
rat-brain (4436) 4436
analysis of variance (4408) 4408
drug therapy (4375) 4375
medicine, research & experimental (4333) 4333
patch-clamp techniques (4304) 4304
neurology (4300) 4300
cell line, tumor (4299) 4299
respiratory system (4292) 4292
molecular sequence data (4270) 4270
binding sites (4236) 4236
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (104) 104
Online Resources - Online (60) 60
UofT at Mississauga - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Gerstein Science - Periodical Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UTL at Downsview - May be requested (7) 7
Gerstein Science - Bindery (5) 5
UofT at Scarborough - Stacks (5) 5
New College (Ivey) - Stacks (3) 3
Robarts - Stacks (2) 2
St. Michael's Hospital - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Storage (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (199548) 199548
German (1749) 1749
French (1497) 1497
Russian (1351) 1351
Japanese (1330) 1330
Chinese (711) 711
Spanish (533) 533
Polish (277) 277
Portuguese (219) 219
Korean (162) 162
Italian (152) 152
Hungarian (96) 96
Czech (92) 92
Danish (89) 89
Swedish (76) 76
Ukrainian (74) 74
Dutch (69) 69
Turkish (47) 47
Norwegian (39) 39
Bulgarian (35) 35
Slovak (23) 23
Finnish (22) 22
Hebrew (21) 21
Romanian (20) 20
Serbian (15) 15
Lithuanian (12) 12
Slovenian (8) 8
Persian (6) 6
Croatian (5) 5
Icelandic (3) 3
Arabic (2) 2
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Progress in brain research, ISBN 0444532358, Volume 172., xv, 665 p. [6] p. of plates
This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the... 
Neurochemistry | Neurotransmitters | Dopamine | Serotonin | Neurochimie
Book
1997, Lung biology in health and disease, ISBN 9780824794965, Volume 106., xvi, 443
Book
2010, ISBN 9780313382802, xiv, 238
Book
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 09/2013, Volume 23, Issue 18, pp. 5082 - 5085
Journal Article
Frontiers in Neuroscience, ISSN 1662-4548, 2015, Volume 9, p. 125
Background: Application of transcranial random noise stimulation (tRNS) between 0.1 and 640 Hz of the primary motor cortex (M1) for 10 min induces a persistent... 
Transcranial magnetic stimulation (TMS) | D-cycloserine (D-CYC: partial NMDA receptor agonist) | Dextromethorphan (DMO: NMDA receptor antagonist) | transcranial random noise stimulation (tRNS) | Carbamazepine (CBZ: sodium channel blocker) | Lorazepam (LOR: GABA A receptor agonist) | Ropinirole (ROP: D 2 /D 3 receptor agonist) | Transcranial direct current stimulation (tDCS) | carbamazepine (CBZ: sodium channel blocker) | CELLS | ACTIVATION | EXCITATION | NEUROPLASTICITY | HUMANS | NEUROSCIENCES | CORTICAL EXCITABILITY | HUMAN MOTOR CORTEX | CONSOLIDATION | ropinirole (ROP: D-2/D-3 receptor agonist) | transcranial magnetic stimulation (TMS) | NONINVASIVE BRAIN-STIMULATION | dextromethorphan (DMO: NMDA receptor antagonist) | transcranial direct current stimulation (tDCS) | MODULATION | lorazepam (LOR: GABA(A) receptor agonist) | Dopamine | Transcranial magnetic stimulation | γ-Aminobutyric acid A receptors | Glutamic acid receptors (ionotropic) | Noise | Cortex | Dopamine D3 receptors | Excitability | N-Methyl-D-aspartic acid receptors | Dextromethorphan | Cortex (motor) | Cycloserine | Benzodiazepines | Carbamazepine | Neurophysiology | Electrical currents | Electrodes | Morphology | Agonists | Lorazepam | Magnetic fields | Electric fields | ropinirole (ROP: D2/D3 receptor agonist) | lorazepam (LOR: GABAA receptor agonist)
Journal Article
Critical Care Medicine, ISSN 0090-3493, 12/2013, Volume 41, Issue 12, pp. e431 - e438
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 905 - 915
Mu-opioid and CB1-cannabinoid agonists produce analgesia; however, adverse effects limit use of drugs in both classes. Additive or synergistic effects... 
Analgesia | Morphine | Marijuana | G-protein | Adenylyl cyclase | CB1 receptors | AGONIST MORPHINE | ACTIVATION | PROTEIN-KINASE | CB1 CANNABINOID RECEPTOR | SYNERGISTIC INTERACTIONS | NEUROSCIENCES | INHIBITION | KAPPA | FULL AGONIST | ADENYLYL-CYCLASE | PHARMACOLOGY & PHARMACY | RAT-BRAIN | Pyrazoles - therapeutic use | Receptor, Cannabinoid, CB2 - agonists | Humans | Analgesics, Opioid - pharmacology | Receptors, Opioid, mu - agonists | Piperidines - pharmacology | Cannabinoid Receptor Agonists - therapeutic use | Recombinant Proteins - antagonists & inhibitors | Piperidines - metabolism | Receptors, Opioid, mu - metabolism | Morpholines - metabolism | Analgesics, Non-Narcotic - metabolism | Drug Inverse Agonism | Mice | Analgesics, Opioid - metabolism | Kinetics | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Analgesics, Opioid - antagonists & inhibitors | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Analgesics, Non-Narcotic - pharmacology | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Analgesics, Opioid - adverse effects | Narcotic Antagonists - metabolism | Receptor, Cannabinoid, CB1 - agonists | Analgesics, Non-Narcotic - adverse effects | Cannabinoid Receptor Agonists - adverse effects | Morpholines - adverse effects | CHO Cells | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Binding, Competitive | Recombinant Proteins - metabolism | Cricetinae | Morpholines - pharmacology | Narcotic Antagonists - adverse effects | Recombinant Proteins - agonists | Analgesics, Non-Narcotic - therapeutic use | Pyrazoles - metabolism | Mice, Inbred Strains | Receptors, Opioid, mu - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Narcotic Antagonists - pharmacology | Piperidines - adverse effects | Receptors, Opioid, mu - genetics | Index Medicus | Drugs | Pain perception | Opioid receptors | Cyclic AMP | Opioid receptors (type mu) | Antagonists | Cannabinoid CB1 receptors | Guanine nucleotide-binding protein | Antagonism | Cell activation | Side effects | Inverse agonists | CB1 Receptors | Adenylyl Cyclase
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2016, Volume 81, Issue 1, pp. 67 - 77
Journal Article
Philosophical Transactions: Biological Sciences, ISSN 0962-8436, 12/2012, Volume 367, Issue 1607, pp. 3353 - 3363
Human tissues express cannabinoid CB₁ and CB₂ receptors that can be activated by endogenously released 'endocannabinoids' or exogenously administered compounds... 
Receptors | Cannabinoids | Animal models | Pain | Medical treatment | Agonists | Morphine | Drug design | Endocannabinoids | Cannabinoid receptors | And CB2 | Blood-brain barrier | Cannabinoid receptor agonists | Δ9-tetrahydrocannabinol | Cannabinoid CB1 | Therapeutic applications and strategies | blood-brain barrier | Delta-tetrahydrocannabinol | cannabinoid CB1 and CB2 receptors | CB2 RECEPTOR | LIVER-DISEASES | AMYOTROPHIC-LATERAL-SCLEROSIS | ANXIETY-LIKE BEHAVIOR | MU-OPIOID RECEPTOR | RAT FORMALIN TEST | therapeutic applications and strategies | cannabinoid receptor agonists | NEUROPATHIC PAIN | MOUSE MODEL | BIOLOGY | PENTYLENETETRAZOLE-INDUCED SEIZURE | CENTRAL-NERVOUS-SYSTEM | Endocannabinoids - metabolism | Analgesics - pharmacology | Receptor, Cannabinoid, CB2 - agonists | Cardiovascular Diseases - drug therapy | Humans | Cannabinoid Receptor Agonists - pharmacology | Neurodegenerative Diseases - drug therapy | Pain - metabolism | Receptor, Cannabinoid, CB1 - agonists | Pain - drug therapy | Cannabinoid Receptor Agonists - therapeutic use | Dronabinol - pharmacology | Analgesics - therapeutic use | Cardiovascular Diseases - metabolism | Risk Assessment | Analgesics - administration & dosage | Clinical Trials as Topic | Neurodegenerative Diseases - metabolism | Blood-Brain Barrier - drug effects | Cannabinoid Receptor Agonists - administration & dosage | Drug Discovery | Blood-Brain Barrier - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Dronabinol - therapeutic use | Review
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 2, pp. 283 - 295
Abstract Background Mirabegron, a β3 -adrenoceptor agonist, has been developed for the treatment of overactive bladder (OAB). Objective To assess the efficacy... 
Urology | Mirabegron | β3-Adrenoceptor agonist | Overactive bladder (OAB) | Adrenoceptor agonist
Journal Article
Journal Article